RCM
LEGN icon

RA Capital Management’s Legend Biotech LEGN Stock Holding History

RA Capital Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7,506,934
Closed -$244M – 92
2024
Q4 		$244M Hold
7,506,934
– – 3.25% 5
2024
Q3 		$366M Hold
7,506,934
– – 4.22% 4
2024
Q2 		$332M Buy
7,506,934
+645,837
+9% +$29.8M 4.4% 4
2024
Q1 		$385M Buy
6,861,097
+596,390
+10% +$36M 4.9% 3
2023
Q4 		$377M Hold
6,264,707
– – 5.89% 4
2023
Q3 		$421M Hold
6,264,707
– – 8.28% 2
2023
Q2 		$432M Buy
6,264,707
+3,828,484
+157% +$250M 8.16% 2
2023
Q1 		$117M Hold
2,436,223
– – 2.66% 10
2022
Q4 		$122M Buy
2,436,223
+97,613
+4% +$4.73M 2.47% 11
2022
Q3 		$95.4M Buy
+2,338,610
New +$110M 2.04% 16
2021
Q3 		– Sell
-977,503
Closed -$40.1M – 101
2021
Q2 		$40.1M Buy
+977,503
New +$33.2M 0.64% 50
2021
Q1 		– Sell
-2,408,292
Closed -$67.8M – 90
2020
Q4 		$67.8M Hold
2,408,292
– – 0.95% 33
2020
Q3 		$74.3M Sell
2,408,292
-73,650
-3% -$2.48M 1.36% 24
2020
Q2 		$106M Buy
+2,481,942
New +$97M 2.06% 17

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RA Capital Management's LEGN Position: Q1 2025 in Review

RA Capital Management sold out of Legend Biotech (LEGN) in Q1 2025, closing a stake of 7,506,934 shares — an estimated $244M sold.

RA Capital Management first reported a position in LEGN in Q2 2020 and held it in 14 quarters. The position peaked at $432M in Q2 2023. 208 funds tracked by Wall St. Rank hold LEGN as of Q1 2025.

  • RA Capital Management reported no remaining Legend Biotech position as of Q1 2025 after selling out during the quarter.
  • RA Capital Management sold 7,506,934 Legend Biotech shares in Q1 2025, an estimated $244M.
  • RA Capital Management first reported a position in Legend Biotech in Q2 2020 and held it in 14 quarters.
  • RA Capital Management's Legend Biotech position peaked at $432M in Q2 2023.
  • 208 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2025.

Based on RA Capital Management's 13F filing for Q1 2025, filed 15 May 2025.